{"id":1256,"date":"2022-01-24T15:54:28","date_gmt":"2022-01-24T14:54:28","guid":{"rendered":"https:\/\/www.olym.nl\/?p=1256"},"modified":"2022-02-25T16:28:17","modified_gmt":"2022-02-25T15:28:17","slug":"sale-of-quantib-to-radnet-inc","status":"publish","type":"post","link":"https:\/\/www.olym.nl\/en\/2022\/1256\/","title":{"rendered":"Sale of Quantib to RadNet Inc."},"content":{"rendered":"<p>We advised the former shareholders of Quantib, including Holland Capital, InnovationQuarter and Erasmus Medical Centre, in the sale of shares in Quantib to RadNet, Inc. (NASDAQ: RDNT), a US leader in providing high-quality diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers. Quantib is a leading radiology artificial intelligence (\u201cAI\u201d) company focusing on clinical solutions for prostate cancer, breast cancer and neurodegeneration.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We advised the former shareholders of Quantib, including Holland Capital, InnovationQuarter and Erasmus Medical Centre, in the sale of shares in Quantib to RadNet, Inc. (NASDAQ: RDNT), a US leader in providing high-quality diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers. Quantib is a leading radiology artificial intelligence (\u201cAI\u201d) company focusing on clinical solutions for prostate cancer, breast cancer and neurodegeneration.<\/p>\n","protected":false},"author":3,"featured_media":871,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[29,33,27,34,31,32],"tags":[],"class_list":{"0":"post-1256","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eveline-mutsaers-en","8":"category-homepage-en","9":"category-lawyers","10":"category-ma-en","11":"category-niels-hofkes-en","12":"category-track-record-en"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts\/1256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/comments?post=1256"}],"version-history":[{"count":1,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts\/1256\/revisions"}],"predecessor-version":[{"id":1257,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts\/1256\/revisions\/1257"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/media\/871"}],"wp:attachment":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/media?parent=1256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/categories?post=1256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/tags?post=1256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}